Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2'-(1H-Tetrazol-5-yl)-1,1'-biphenyl-4-carboxaldehyde (Losartan IMpurity) | C14H10N4O | 151052-40-3 | Details |
| 2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81 | C33H24N4O | 155983-56-5 | Details |
| diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate | C45H42N6O4 | 144690-53-9 | Details |
| Irbesartan Impurity 14 | C25H28N6O | 133690-91-2 | Details |
| Irbesartan Impurity 3 | C14H11N7 | 152708-24-2 | Details |
| Olmesartan Medoxomil Impurity E | C26H30N6O3 | 144689-23-6 | Details |
| Losartan EP Impurity B | C14H12N4O | 160514-13-6 | Details |
| Olmesartan Medoxomil Impurity 25;2-propyl-1H-imidazole-4,5-dicarboxylic acid | C10H16N2O3 | 144690-04-0 | Details |
| Olmesartan | C24H26N6O3 | 144689-24-7 | Details |
| (4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID | C8H11NO4 | 142274-08-6 | Details |
| 4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid | C14H11N3O2 | 2758005-15-9 | Details |
| Irbesartan Impurity 24 | C14H12N4O | 2763750-28-1 | Details |
| 2(e),4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetraazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | C48H44N6O6 | 1203671-69-5 | Details |
| Telmisartan Impurity 10 | C14H10ClN | 136304-93-3 | Details |
| 1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- | C22H22N6O3 | 1820891-36-8 | Details |
| diethyl 2-propylimidazoledicarbonate | C12H18N2O4 | 144689-94-1 | Details |
| DMDO | C5H6O3 | 37830-90-3 | Details |
| Piracetam | C6H10N2O2 | 7491-74-9 | Details |
| Olmesartan Impurity 52 | C8H10N2O4 | 58954-23-7 | Details |
| GLYCINE ANHYDRIDE | C4H6N2O2 | 106-57-0 | Details |
| 5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole | C33H26N4 | 124750-53-4 | Details |
| Irbesartan Impurity 15 | C14H11NO | 154709-19-0 | Details |
| 1,3-Benzenediamine, 4,6-dimethoxy-N1-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- | C21H21N5O2 | 1942853-79-3 | Details |
| oxiracetam impurity III | C6H8N2O2 | 62833-66-3 | Details |
| oxiracetam impurity VI | C7H11NO4 | 85614-52-4 | Details |
| 4-hydroxypyrrolidin-2-one | C4H7NO2 | 25747-41-5 | Details |
| oxiracetam impurity IV | C6H9NO4 | 77191-37-8 | Details |
| oxiracetaM related substance ISF3886 | C8H13N3O4 | 120428-80-0 | Details |
| oxiracetam impurity VII | C8H13NO4 | 62613-81-4 | Details |
| Osimertinib Impurity 21 | C23H20FN5O2 | 2213409-62-0 | Details |
| Osimertinib Impurity 19 | C32H39N7O4 | 1421373-33-2 | Details |
| Osimertinib Impurity 15 | C29H37N7O3 | 1421373-34-3 | Details |
| Osimertinib Impurity 16 | C24H29N7O | 1421373-31-0 | Details |
| 2-Pyrimidinamine, N-(2,4-dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)- | C21H19N5O4 | 1942853-78-2 | Details |
| Vonoprazan Impurity 14 | C16H10FN3O2S | 1807642-39-2 | Details |
| Osimertinib Impurity 22 | C19H14FN5O3 | 1421372-34-0 | Details |
| Vonoprazan Impurity | C21H20FN3O6S | 1885094-63-2 | Details |
| Vonoprazan Impurity | C11H7FN2O | 312307-69-0 | Details |
| 2-Propenamide, N-[3-[[4-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]- | C27H28F3N7O3 | 1888303-01-2 | Details |
| TAK438 Impurity 112 | 2932441-73-9 | Details |
| Osimertinib Impurity 23 | C27H31N7O2 | 1421373-99-0 | Details |
| Vonoprazan Impurity X Fumaric acid | C21H21N3O6S | 928325-82-0 | Details |
| Osimertinib Impurity 29 | C24H27N7O3 | 2408329-87-1 | Details |
| C31H37F3N8O4 | 1548527-26-9 | Details |
| Osimertinib Impurity 14 | C24H27N7O3 | 1421373-32-1 | Details |
| N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | C25H26N6O2 | 2044702-39-6 | Details |
| Osimertinib Impurity 11 | C28H33N7O3 | 1975982-94-5 | Details |
| (2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol | C33H26N4O | 154709-18-9 | Details |
| Vonoprazan Impurity D | C11H10FNO | 881674-58-4 | Details |
| Osimertinib Impurity 30 | C28H34ClN7O2 | 1421373-36-5 | Details |
| 2-Propenamide, N-[2,4-dimethoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- | C24H23N5O3 | 1942853-18-0 | Details |
| Osimertinib Impurity 17 | C27H33N7O2 | 2227103-37-7 | Details |
| Osimertinib Impurity 18 | C22H24N6O | 1801616-92-1 | Details |
| Olmesartan Medoxomil Impurity 32 | C49H46N6O6 | 1040405-56-8 | Details |
| Osimertinib Impurity 20 | C20H18FN5O | 1801616-73-8 | Details |
| Osimertinib Impurity 13 | C29H35N7O5 | 1421373-35-4 | Details |
| Osimertinib Impurity 12 | C31H35N7O3 | 1932710-29-6 | Details |
| 2-Propenamide, N-[3-[[2-[[2-methoxy-4-(1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]- | C25H26F3N7O2 | 2763827-03-6 | Details |
| Osimertinib Impurity I | C22H25ClN6O | 2044702-55-6 | Details |
| Ethanone, 1-[4-[4-[[2-[(3-aminophenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]-3-methoxyphenyl]-1-piperazinyl]- | C24H26F3N7O2 | 2044703-15-1 | Details |
| Benzofuran-6-carboxylicacid(LifitegrastImpurity) | C9H6O3 | 77095-51-3 | Details |
| Celecoxib Carboxylic Acid | C17H12F3N3O4S | 170571-01-4 | Details |
| Vonoprazan Impurity 10 | C16H13FN2O3S | 2169271-28-5 | Details |
| Lifitegrast Impurity 8 | C29H24Cl2N2O7S | 2271299-08-0 | Details |
| Lifitegrast Impurity 7 | C19H13Cl2NO4 | 2129597-34-6 | Details |
| benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate | C36H30Cl2N2O7S | 1194550-67-8 | Details |
| methyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoate hydrochloride | C21H23Cl3N2O5S | 2758051-12-4 | Details |
| C19H17NO6S | 2982988-09-8 | Details |
| Celecoxib Impurity 30 | C11H9F3O2 | 53764-99-1 | Details |
| Gluconic acid | C6H12O7 | 526-95-4 | Details |
| Celecoxib Impurity A | C17H14F3N3O2S | 170570-01-1 | Details |
| Celecoxib Impurity F | C17H14F3N3O2S | 170569-99-0 | Details |
| (R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid | C10H13NO4S | 1270132-45-0 | Details |
| 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline | C9H9Cl2N | 89315-56-0 | Details |
| Isoquinoline, 5,7-dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)- | C28H23Cl2N | 1289646-72-5 | Details |
| Boc-3-(Methylsulfonyl)-L-Phenylalanine | C15H21NO6S | 1289646-76-9 | Details |
| Vonoprazan Impurity | C16H11FN2O4S | 1883595-37-6 | Details |
| Lifitegrast Impurity 26 | C30H26Cl2N2O7S | 2295862-29-0 | Details |
| Lifitegrast Impurity 28 | C26H23NO6S | 2982988-08-7 | Details |
| 4,4,4-Trifluoro-1-(p-tolyl)-1,3-butanedione | C11H9F3O2 | 720-94-5 | Details |
| Celecoxib iMpurity-G | C15H17N3O2S | 1061214-06-9 | Details |
| 2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | C15H17Cl2NO4 | 851784-82-2 | Details |
| ifitegrast impurity C | C20H20Cl2N2O5S | 851785-70-1 | Details |
| Celebrex P | C17H13F3N2O3S | 921617-76-7 | Details |
| Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]- | C14H15N3O2S | 1135952-91-8 | Details |
| benzyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate | C17H20ClNO4S | 1194550-59-8 | Details |
| 4,4,4-Trifluoro-1-phenyl-1,3-butanedione | C10H7F3O2 | 326-06-7 | Details |
| Lifitegrast Impurity 51 | C10H14ClNO4S | 2177264-60-5 | Details |
| Vonoprazan Impurity U9 | C18H18FN3O2S | 1885094-62-1 | Details |
| 2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-, 1,1-dimethylethyl ester | C14H17Cl2NO2 | 2215846-47-0 | Details |
| Lifitegrast Impurity 3 | C27H27Cl3N2O5S | 1194550-65-6 | Details |
| 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride | C10H10Cl3NO2 | 1289646-93-0 | Details |
| ethyl benzofuran-6-carboxylate;Lifitegrast Impurity 32 | C11H10O3 | 1289646-90-7 | Details |
| Vonoprazan Impurity | C22H24FN3O4S | 1831110-76-9 | Details |
| Celecoxib Impurity 3 | C16H12F3N3O2S | 170569-87-6 | Details |
| Lifitegrast Impurity 15 | C17H20ClNO4S | 2049127-88-8 | Details |
| Celecoxib Impurity 17 | C17H14F3N3O4S | 2247197-65-3 | Details |
| Product Total: Product Page: | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||